glp-1 news 2025 november trends 2025: real-world data, patient outcomes & future therapies Alarming rise in weight loss

Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs

They also believe GLP-1 coverage would enhance employees' health and perception of healthcare benefits: 79% agree that GLP-1 coverage will help employees' health long term 77% agree that GLP-1 coverage would make employees feel they get a better health insurance package What employers already covering GLP-1s have to say Companies already covering GLP-1s (25%) say they plan to continue covering them (99%), providing perspective on balancing financial impact with employee engagement and satisfaction

The increased number of effective obesity treatments, I think, has reduced the stigma against treating obesity a little bit more, in part because these trials have shown the other health benefits for treating obesity

BMI requirements for each GLP-1 medication Semaglutide: Wegovy and Ozempic Semaglutide operates through two branded formulations with different approved indications, and the BMI requirements vary accordingly